She and his colleagues revealed that overexpression of FAIM2 is associated with dismal clinical outcome for lung cancer, and silencing FAIM2 may inhibit tumor cell viability and anoikis resistance [8]. This evidence concerns the gene FAIM2 and lung carcinoma.